Nucleoside (Acid) Analogues Treatment in Patients With Normal ALT and Positive HBVDNA.

Abroad (travel likely)Recruiting

Conditions

Hepatitis B Virus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
Contact: Study coordinator (Liang Peng, Doctor) · pzp33@hotmail.com · +8613533978874

Study leads

Liang Peng, Doctor
Principal Investigator
Third Affiliated Hospital, Sun Yat-Sen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Hepatitis B · Acute-On-Chronic Liver Failure

Abroad (travel likely)Recruiting

Guangzhou, China

Evaluation of Patients With Liver Disease

Hepatitis D · Hepatitis C · Hepatitis B

Abroad (travel likely)Recruiting

Bethesda, United States

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of GIGA-2339 in Participants With Chronic Hepatitis B Virus Infection

Hepatitis B Virus Infection

Abroad (travel likely)RecruitingPHASE1

Chandler, United States · Huntington Beach, United States

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Chronic Hepatitis B Virus Infection

Abroad (travel likely)RecruitingPHASE1

Chisinau, Moldova · Auckland, New Zealand